Company Filing History:
Years Active: 2008-2012
Title: Oliver Heinrich: Innovator in Lipolytic Enzymes
Introduction
Oliver Heinrich is a notable inventor based in Martinsried, Germany. He has made significant contributions to the field of biotechnology, particularly in the development of lipolytic enzymes. With a total of 3 patents to his name, Heinrich's work has implications for both industrial processes and medical diagnostics.
Latest Patents
Heinrich's latest patents focus on a newly identified polynucleotide sequence that encodes a novel lipolytic enzyme. This invention includes the full-length nucleotide sequence of the gene, the cDNA sequence that comprises the full-length coding sequence, and the amino acid sequence of the functional protein. The patents also describe methods for utilizing these enzymes in industrial applications and for diagnosing fungal infections. Additionally, the inventions encompass cells that have been transformed with the polynucleotide and those in which the lipolytic enzyme has been genetically modified to enhance its activity and expression levels.
Career Highlights
Oliver Heinrich is associated with Dsm IP Assets B.V., where he continues to innovate in the field of enzyme technology. His work has garnered attention for its potential applications in various industries, including pharmaceuticals and agriculture.
Collaborations
Heinrich collaborates with notable colleagues such as Christian Wagner and Andreas Fritz, contributing to a dynamic research environment that fosters innovation.
Conclusion
Oliver Heinrich's contributions to the field of biotechnology, particularly through his patents on lipolytic enzymes, highlight his role as a key innovator. His work not only advances scientific understanding but also opens new avenues for industrial and medical applications.